Print

14 New Biomarkers Identified for Type 2 Diabetes, German Institute of Human Nutrition (DIfE) and Max Delbruck Center Study  
10/5/2012 7:39:44 AM

A research team led by Anna Floegel of the German Institute of Human Nutrition (DIfE) and Tobias Pischon of the Max Delbrueck Center for Molecular Medicine (MDC) has identified 14 novel biomarkers for type 2 diabetes. They can serve as basis for developing new methods of treatment and prevention of this metabolic disease. The biomarkers can also be used to determine diabetes risk at a very early point in time. At the same time the markers enable insight into the complex mechanisms of this disease, which still have not been completely elucidated.
//-->